The Lantibiotic Peptide Labyrinthopeptin A1 Demonstrates Broad Anti-HIV and Anti-HSV Activity with Potential for Microbicidal Applications

Herpes simplex virus and HIV: genital infection synergy and novel approaches to dual prevention

(2012) A R Thurman et al.   INTERNATIONAL JOURNAL OF STD & AIDS

Deuterium Labeled Peptides Give Insights into the Directionality of Class III Lantibiotic Synthetase LabKC

(2012) Bartlomiej Krawczyk et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

Feglymycin, a unique natural bacterial antibiotic peptide, inhibits HIV entry by targeting the viral envelope protein gp120

(2012) Geoffrey Férir et al.   VIROLOGY

Twice-Daily Application of HIV Microbicides Alter the Vaginal Microbio

(2012) J. Ravel et al.   mBio

Safety and effectiveness of BufferGel and 0.5% PRO2000 gel for the prevention of HIV infection in women

(2011) Salim S Abdool Karim et al.   AIDS

Leader Peptide-Directed Processing of Labyrinthopeptin A2 Precursor Peptide by the Modifying Enzyme LabKC

(2011) Wolfgang M. Müller et al.   BIOCHEMISTRY

Topical Tenofovir, a Microbicide Effective against HIV, Inhibits Herpes Simplex Virus-2 Replication

(2011) Graciela Andrei et al.   Cell Host & Microbe

Prevention of vaginal SHIV transmission in macaques by a live recombinant Lactobacillus

(2011) L A Lagenaur et al.   Mucosal Immunology

A time-of–drug addition approach to target identification of antiviral compounds

(2011) Dirk Daelemans et al.   Nature Protocols

Fusing structure and function: a structural view of the herpesvirus entry machinery

(2011) Sarah A. Connolly et al.   NATURE REVIEWS MICROBIOLOGY

HIV sexual transmission and microbicides

(2011) Kevin K. Ariën et al.   REVIEWS IN MEDICAL VIROLOGY

Herpes simplex virus infects most cell types in vitro: clues to its success

(2011) Ghadah A Karasneh et al.   Virology Journal

Pharmacokinetic Assessment of Dapivirine Vaginal Microbicide Gel in Healthy, HIV-Negative Women

(2010) Annalene M. Nel et al.   AIDS RESEARCH AND HUMAN RETROVIRUSES

Labyrinthopeptins: A New Class of Carbacyclic Lantibiotics

(2010) Kathrin Meindl et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

In Vitro Biosynthesis of the Prepeptide of Type-III Lantibiotic Labyrinthopeptin A2 Including Formation of a CC Bond as a Post-Translational Modification

(2010) Wolfgang M. Müller et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

Actinohivin, a Broadly Neutralizing Prokaryotic Lectin, Inhibits HIV-1 Infection by Specifically Targeting High-Mannose-Type Glycans on the gp120 Envelope

(2010) B. Hoorelbeke et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Vaginal microbiome of reproductive-age women

(2010) J. Ravel et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in Women

(2010) Q. Abdool Karim et al.   SCIENCE

Primary mutations selected in vitro with raltegravir confer large fold changes in susceptibility to first-generation integrase inhibitors, but minor fold changes to inhibitors with second-generation resistance profiles

(2010) Olivia Goethals et al.   VIROLOGY

Safety and Availability of Dapivirine (TMC120) Delivered from an Intravaginal Ring

(2009) J. Romano et al.   AIDS RESEARCH AND HUMAN RETROVIRUSES

Entry inhibitors in the treatment of HIV-1 infection

(2009) John C. Tilton et al.   ANTIVIRAL RESEARCH

Assessment of cervicovaginal cytokine levels following exposure to microbicide Nisin gel in rabbits

(2008) C.C. Aranha et al.   CYTOKINE

Safety concerns for the potential use of cyanovirin-N as a microbicidal anti-HIV agent

(2008) Dana Huskens et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY